Evidence map›Paper›PMID 30423908›Full record

ArticleJournal of functional biomaterials2018

Development and Application of an Additively Manufactured Calcium Chloride Nebulizer for Alginate 3D-Bioprinting Purposes.

Lukas Raddatz, Antonina Lavrentieva, Iliyana Pepelanova, Janina Bahnemann, Dominik Geier, Thomas Becker, Thomas Scheper, Sascha Beutel

Open access · goldAbstract read
In one paragraph

Article in Journal of functional biomaterials, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 1 pooled it
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 1 synthesis or guideline pooled it, 35 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Diffusion-Based 3D Bioprinting Strategies.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2024
    Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Overview of Current Advances in Extrusion Bioprinting for Skin Applications.International journal of molecular sciences · 2020
    Review
  12. Article
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Lukas RaddatzInstitut für Technische Chemie, Leibniz Universität Hannover, Callinstraße 5, 30167 Hannover, Germany. raddatz@iftc.uni-hannover.de.ORCID 0000-0002-4170-8318
Antonina LavrentievaInstitut für Technische Chemie, Leibniz Universität Hannover, Callinstraße 5, 30167 Hannover, Germany. lavrentieva@iftc.uni-hannover.de.
Iliyana PepelanovaInstitut für Technische Chemie, Leibniz Universität Hannover, Callinstraße 5, 30167 Hannover, Germany. pepelanova@iftc.uni-hannover.de.
Janina BahnemannInstitut für Technische Chemie, Leibniz Universität Hannover, Callinstraße 5, 30167 Hannover, Germany. jbahnemann@iftc.uni-hannover.de.ORCID 0000-0002-7008-1673
Dominik GeierLehrstuhl für Brau- und Getränketechnologie, Technische Universität München, Weihenstephaner Steig 20, 80354 Freising, Germany. dominik.geier@tum.de.
Thomas BeckerLehrstuhl für Brau- und Getränketechnologie, Technische Universität München, Weihenstephaner Steig 20, 80354 Freising, Germany. tb@tum.de.
Thomas ScheperInstitut für Technische Chemie, Leibniz Universität Hannover, Callinstraße 5, 30167 Hannover, Germany. scheper@iftc.uni-hannover.de.
Sascha BeutelInstitut für Technische Chemie, Leibniz Universität Hannover, Callinstraße 5, 30167 Hannover, Germany. beutel@iftc.uni-hannover.de.
Leibniz University Hannover · DETechnical University of Munich · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Three-dimensional (3D)-bioprinting enables scientists to mimic in vivo micro-environments and to perform in vitro cell experiments under more physiological conditions than is possible with conventional two-dimensional (2D) cell culture. Cell-laden biomaterials (bioinks) are precisely processed to bioengineer tissue three-dimensionally. One primarily used matrix material is sodium alginate. This natural biopolymer provides both fine mechanical properties when gelated and high biocompatibility. Commonly, alginate is 3D bioprinted using extrusion based devices. The gelation reaction is hereby induced by a CaCl₂ solution in the building chamber after material extrusion. This established technique has two main disadvantages: (1) CaCl₂ can have toxic effects on the cell-laden hydrogels by oxygen diffusion limitation and (2) good printing resolution in the CaCl₂ solution is hard to achieve, since the solution needs to be removed afterwards and substituted by cell culture media. Here, we show an innovative approach of alginate bioprinting based on a CaCl₂ nebulizer. The device provides CaCl₂ mist to the building platform inducing the gelation. The necessary amount of CaCl₂ could be decreased as compared to previous gelation strategies and limitation of oxygen transfer during bioprinting can be reduced. The device was manufactured using the MJP-3D printing technique. Subsequently, its digital blueprint (CAD file) can be modified and additive manufactured easily and mounted in various extrusion bioprinters. With our approach, a concept for a more gentle 3D Bioprinting method could be shown. We demonstrated that the concept of an ultrasound-based nebulizer for CaCl₂ mist generation can be used for 3D bioprinting and that the mist-induced polymerization of alginate hydrogels of different concentrations is feasible. Furthermore, different cell-laden alginate concentrations could be used: Cell spheroids (mesenchymal stem cells) and single cells (mouse fibroblasts) were successfully 3D printed yielding viable cells and stable hydrogels after 24 h cultivation. We suggest our work to show a different and novel approach on alginate bioprinting, which could be useful in generating cell-laden hydrogel constructs for e.g., drug screening or (soft) tissue engineering applications.

Indexed as

3D printingalginatebioinkbioprintingcell culture technologycustomizable labwarehydrogelsrapid tooling

Identifiers

PMID30423908
PMCPMC6306849
OpenAlexW2899714826

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.